Titan Pharmaceuticals Inc (TTNP)
7.01
-0.31
(-4.23%)
USD |
NASDAQ |
Apr 22, 16:00
7.02
+0.01
(+0.14%)
After-Hours: 20:00
Titan Pharmaceuticals Free Cash Flow (Quarterly): -2.246M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.246M |
| September 30, 2023 | -1.835M |
| June 30, 2023 | -1.112M |
| March 31, 2023 | -1.899M |
| December 31, 2022 | -1.579M |
| September 30, 2022 | -1.873M |
| June 30, 2022 | -1.767M |
| March 31, 2022 | -2.964M |
| December 31, 2021 | -1.086M |
| September 30, 2021 | -2.262M |
| June 30, 2021 | -1.949M |
| March 31, 2021 | -2.625M |
| December 31, 2020 | -4.57M |
| September 30, 2020 | -3.891M |
| June 30, 2020 | -4.04M |
| March 31, 2020 | -5.242M |
| December 31, 2019 | -3.775M |
| September 30, 2019 | -3.386M |
| June 30, 2019 | -4.188M |
| March 31, 2019 | -4.352M |
| December 31, 2018 | -3.653M |
| September 30, 2018 | -2.286M |
| June 30, 2018 | -1.851M |
| March 31, 2018 | -1.057M |
| December 31, 2017 | -3.522M |
| Date | Value |
|---|---|
| September 30, 2017 | -3.674M |
| June 30, 2017 | -2.52M |
| March 31, 2017 | -3.136M |
| December 31, 2016 | -2.483M |
| September 30, 2016 | -2.816M |
| June 30, 2016 | 13.52M |
| March 31, 2016 | -2.095M |
| December 31, 2015 | -1.833M |
| September 30, 2015 | -1.809M |
| June 30, 2015 | -1.924M |
| March 31, 2015 | -2.033M |
| December 31, 2014 | -1.572M |
| September 30, 2014 | -1.403M |
| June 30, 2014 | -1.349M |
| March 31, 2014 | -1.559M |
| December 31, 2013 | -2.125M |
| September 30, 2013 | -2.178M |
| June 30, 2013 | -3.93M |
| March 31, 2013 | -1.884M |
| December 31, 2012 | 9.364M |
| September 30, 2012 | -2.51M |
| June 30, 2012 | -3.124M |
| March 31, 2012 | -3.054M |
| December 31, 2011 | -2.366M |
| September 30, 2011 | -3.32M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-5.242M
Minimum
Mar 2020
-1.086M
Maximum
Dec 2021
-2.752M
Average
-2.262M
Median
Sep 2021
Free Cash Flow (Quarterly) Benchmarks
| Outset Medical Inc | -25.50M |
| Allurion Technologies Inc | -21.27M |
| AIM ImmunoTech Inc | -9.956M |
| Protalix BioTherapeutics Inc | 3.345M |
| Armata Pharmaceuticals Inc | -10.51M |